BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Celik I, Tallei TE. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA-dependent RNA polymerase of wild-type and Delta subvariant AY.4 of SARS-CoV-2. J Cell Biochem 2022. [PMID: 35132671 DOI: 10.1002/jcb.30226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Teli D, Balar P, Patel K, Sharma A, Chavda V, Vora L. Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants. Metabolites 2023;13. [PMID: 36837928 DOI: 10.3390/metabo13020309] [Reference Citation Analysis]
2 Bender O, Celik I, Dogan R, Atalay A, Shoman ME, Ali TFS, Beshr EAM, Mohamed M, Alaaeldin E, Shawky AM, Awad EM, Ahmed AF, Younes KM, Ansari M, Anwar S. Vanillin-Based Indolin-2-one Derivative Bearing a Pyridyl Moiety as a Promising Anti-Breast Cancer Agent via Anti-Estrogenic Activity. ACS Omega 2023;8:6968-81. [PMID: 36844536 DOI: 10.1021/acsomega.2c07793] [Reference Citation Analysis]
3 Rabaan AA, Abas AH, Tallei TE, Al-Zaher MA, Al-Sheef NM, Fatimawali, Al-Nass EZ, Al-Ebrahim EA, Effendi Y, Idroes R, Alhabib MF, Al-Fheid HA, Adam AA, Bin Emran T. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies. J Med Virol 2023;95:e28306. [PMID: 36372558 DOI: 10.1002/jmv.28306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Çetiner G, Çevik UA, Celik I, Bostancı HE, Özkay Y, Kaplancıklı ZA. New Imidazole Derivatives as Aromatase Inhibitor: Design, Synthesis, Biological Activity, Molecular Docking, and Computational ADME-Tox Studies. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.134920] [Reference Citation Analysis]
5 Celik I, Çevik UA, Karayel A, Işık A, Kayış U, Gül ÜD, Bostancı HE, Konca SF, Özkay Y, Kaplancıklı ZA. Synthesis, Molecular Docking, Dynamics, Quantum-Chemical Computation, and Antimicrobial Activity Studies of Some New Benzimidazole-Thiadiazole Hybrids. ACS Omega 2022;7:47015-30. [PMID: 36570216 DOI: 10.1021/acsomega.2c06142] [Reference Citation Analysis]
6 Pagliano P, Sellitto C, Ascione T, Scarpati G, Folliero V, Piazza O, Franci G, Filippelli A, Conti V. The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19). Expert Opin Drug Discov 2022;17:1299-311. [PMID: 36508255 DOI: 10.1080/17460441.2022.2153828] [Reference Citation Analysis]
7 Das S, Rai S, Mandal M. M-polynomial and Correlated Topological Indices of Antiviral Drug Molnupiravir Used as a Therapy for COVID-19. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2131854] [Reference Citation Analysis]
8 Celik I, Sarıaltın SY, Çoban T, Kılcıgil G. Design, Synthesis, in Vitro and in Silico Studies of Benzimidazole‐Linked Oxadiazole Derivatives as Anti‐inflammatory Agents. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201548] [Reference Citation Analysis]
9 Celik I, Abdellattif MH, Tallei TE. An Insight Based on Computational Analysis of the Interaction between the Receptor-Binding Domain of the Omicron Variants and Human Angiotensin-Converting Enzyme 2. Biology (Basel) 2022;11:797. [PMID: 35625526 DOI: 10.3390/biology11050797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dong R, Hu T, Zhang Y, Li Y, Zhou X. Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron. Vaccines 2022;10:496. [DOI: 10.3390/vaccines10040496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]